ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.962,46
0,23%
S&P 500
5.018,39
0,00%
Dow Jones
37.903,29
0,00%
Euro vs US Dollar
1,07087
-0,08%
Bitcoin
58.631,43
0,68%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. West Pharmaceutical Services Inc (WST)

  7. West Pharmaceutical Services Inc (WST) News

WST

West Pharmaceutical Serv... (WST)

West Pharmaceutical Services Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:WST
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202412h00PR Newswire (US)West to Participate in Upcoming Investor ConferenceNYSE:WSTWest Pharmaceutical Services Inc
25/04/202412h00PR Newswire (US)West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
11/04/202412h00PR Newswire (US)West to Host First-Quarter 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
01/03/202422h24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:WSTWest Pharmaceutical Services Inc
01/03/202419h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
29/02/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
28/02/202422h30PR Newswire (US)West to Participate in Upcoming Investor ConferencesNYSE:WSTWest Pharmaceutical Services Inc
27/02/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:WSTWest Pharmaceutical Services Inc
27/02/202417h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
23/02/202400h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
20/02/202422h44Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:WSTWest Pharmaceutical Services Inc
20/02/202412h00PR Newswire (US)West Announces Second-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
15/02/202413h51Edgar (US Regulatory)Form 8-K - Current reportNYSE:WSTWest Pharmaceutical Services Inc
15/02/202412h00PR Newswire (US)West Announces Fourth-Quarter and Full-Year 2023 ResultsNYSE:WSTWest Pharmaceutical Services Inc
07/02/202414h00PR Newswire (US)West Named to Newsweek's America's Greatest Workplaces 2024 for DiversityNYSE:WSTWest Pharmaceutical Services Inc
01/02/202412h00PR Newswire (US)West to Host Fourth-Quarter and Full-Year 2023 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
24/01/202423h23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
21/12/202318h54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
13/12/202322h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
08/12/202321h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
06/12/202312h00PR Newswire (US)West Announces First-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
06/12/202301h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
 Showing the most relevant articles for your search:NYSE:WST

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
EURGBP
Euro vs Sterling
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
CCOM
US500
US 500
COIN
ETHUSD
Ethereum
TG
432
Arbor Metals
NYSE
XOM
Exxon Mobil
TG
ALV
Allianz
TG
MBG
MercedesBenz
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten